» Articles » PMID: 29665143

Identification of Potential Tumor-educated Platelets RNA Biomarkers in Non-small-cell Lung Cancer by Integrated Bioinformatical Analysis

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2018 Apr 18
PMID 29665143
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Platelets have emerged as key players in tumorigenesis and tumor progression. Tumor-educated platelet (TEP) RNA profile has the potential to diagnose non-small-cell lung cancer (NSCLC). The objective of this study was to identify potential TEP RNA biomarkers for the diagnosis of NSCLC and to explore the mechanisms in alternations of TEP RNA profile.

Methods: The RNA-seq datasets GSE68086 and GSE89843 were downloaded from Gene Expression Omnibus DataSets (GEO DataSets). Then, the functional enrichment of the differentially expressed mRNAs was analyzed by the Database for Annotation Visualization and Integrated Discovery (DAVID). The miRNAs which regulated the differential mRNAs and the target mRNAs of miRNAs were identified by miRanda and miRDB. Then, the miRNA-mRNA regulatory network was visualized via Cytoscape software.

Results: Twenty consistently altered mRNAs (2 up-regulated and 18 down-regulated) were identified from the two GSE datasets, and they were significantly enriched in several biological processes, including transport and establishment of localization. Twenty identical miRNAs were found between exosomal miRNA-seq dataset and 229 miRNAs that regulated 20 consistently differential mRNAs in platelets. We also analyzed 13 spliceosomal mRNAs and their miRNA predictions; there were 27 common miRNAs between 206 differential exosomal miRNAs and 338 miRNAs that regulated 13 distinct spliceosomal mRNAs.

Conclusion: This study identified 20 potential TEP RNA biomarkers in NSCLC for diagnosis by integrated bioinformatical analysis, and alternations in TEP RNA profile may be related to the post-transcriptional regulation and the splicing metabolisms of spliceosome.

Citing Articles

Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. "Re-discovering the neglected biosources of the liquid biopsy family".

Gottardo A, Gristina V, Perez A, Di Giovanni E, Contino S, Barraco N J Liq Biopsy. 2025; 3:100136.

PMID: 40026563 PMC: 11863699. DOI: 10.1016/j.jlb.2024.100136.


Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.

Tao X, Li Q, Zeng Y Mol Cancer. 2024; 23(1):145.

PMID: 39014366 PMC: 11250976. DOI: 10.1186/s12943-024-02063-2.


Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.

Mondal D, Shinde S, Sinha V, Dixit V, Paul S, Gupta R Front Mol Biosci. 2024; 11:1385238.

PMID: 38770216 PMC: 11103528. DOI: 10.3389/fmolb.2024.1385238.


CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

Hudson A, Cho A, Colvin E, Hayes S, Wheeler H, Howell V Cancers (Basel). 2024; 16(5).

PMID: 38473425 PMC: 10931055. DOI: 10.3390/cancers16051069.


Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA.

Vermeirssen V, Deleu J, Morlion A, Everaert C, De Wilde J, Anckaert J NAR Cancer. 2022; 4(4):zcac037.

PMID: 36451702 PMC: 9703587. DOI: 10.1093/narcan/zcac037.


References
1.
Zimmerman G, Weyrich A . Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol. 2008; 28(3):s17-24. PMC: 2594008. DOI: 10.1161/ATVBAHA.107.160218. View

2.
Gamez B, Rodriguez-Carballo E, Ventura F . MicroRNAs and post-transcriptional regulation of skeletal development. J Mol Endocrinol. 2014; 52(3):R179-97. DOI: 10.1530/JME-13-0294. View

3.
Hobert O . Gene regulation by transcription factors and microRNAs. Science. 2008; 319(5871):1785-6. DOI: 10.1126/science.1151651. View

4.
Davila J, Manwani D, Vasovic L, Avanzi M, Uehlinger J, Ireland K . A novel inflammatory role for platelets in sickle cell disease. Platelets. 2014; 26(8):726-9. DOI: 10.3109/09537104.2014.983891. View

5.
Calverley D, Phang T, Choudhury Q, Gao B, Oton A, Weyant M . Significant downregulation of platelet gene expression in metastatic lung cancer. Clin Transl Sci. 2011; 3(5):227-32. PMC: 3427741. DOI: 10.1111/j.1752-8062.2010.00226.x. View